Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
240 participants
INTERVENTIONAL
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure
NCT07173426
Safety of Body Composition Analysis in Heart Failure Patients With Implantable Cardioverter Defibrillators (ICDs)
NCT01568606
Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial
NCT01570153
Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement
NCT01711281
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation
NCT02134379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BCM group
The patients are measured by Body Composition Monitor (BCM) and both the patient and the physician know the results and adjust the diuretic therapy accordingly.
Body Composition Monitor (BCM)
In the experimental group, the diuretic therapy adjusted according to the result of the BCM analysis.
Control group
The patients are measured by Body Composition Monitor (BCM) but neither the patient nor the physician know the results, the physician adjusts the diuretic therapy as usual, according to the protocols.
Body Composition Monitor (BCM)
In the experimental group, the diuretic therapy adjusted according to the result of the BCM analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Body Composition Monitor (BCM)
In the experimental group, the diuretic therapy adjusted according to the result of the BCM analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Amputated upper and/or lower limb(s)
* The BCM analysis is not possible technically (e.g. open wounds on the limbs)
* Severe obesity (\>130 kg)
* Patients on chronic hemodialysis or peritoneal dialysis
* Severe fluid volume in the transcellular space
* Patients with a unipolar pacemaker whose sensitivity threshold is very low
* Pregnancy, lactation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peter Studinger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Studinger
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Studinger, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
First Department of Medicine, Semmelweis University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Department of Medicine, Semmelweis University
Budapest, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HF-BCM-15-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.